Biomedical Laboratory Science

ShareThis

Showing posts with label Antimicrobial resistance. Show all posts
Showing posts with label Antimicrobial resistance. Show all posts

Tuesday, June 21, 2016

Antimicrobial resistance: a collection of reviews and research papers from Nature journals

Resistance to antimicrobials is a global problem of increasing importance. Pathogens rapidly develop mutations that render current treatments ineffective. For example, resistance to carbapenems, one of the ‘last lines’ of antibiotics, is widespread and has been observed in numerous countries; resistance to artemisinin, the gold standard in malaria treatment, has also emerged. Our current arsenal of antimicrobial agents thus has a limited lifespan and new drugs are urgently needed. Tackling this resistance will require a deep understanding of microbial infections and the mechanisms through which resistance arises, as well as concerted efforts between academia and industry aimed at developing novel antimicrobial agents.

This collection consists of Reviews, Research articles, and News and Comment articles from several Nature journals, describing how antibiotic resistance emerges and detailing strategies through which new antimicrobial compounds are being discovered.



Source: nature

Friday, May 27, 2016

The superbug that doctors have been dreading just reached the U.S.

For the first time, researchers have found a person in the United States carrying bacteria resistant to antibiotics of last resort, an alarming development that the top U.S. public health official says could mean “the end of the road” for antibiotics.

The antibiotic-resistant strain was found last month in the urine of a 49-year-old Pennsylvania woman. Defense Department researchers determined that she carried a strain of E. coli resistant to the antibiotic colistin, according to a study published Thursday in Antimicrobial Agents and Chemotherapy, a publication of the American Society for Microbiology. The authors wrote that the discovery “heralds the emergence of a truly pan-drug resistant bacteria.”


Source: washingtonpost

Not unexpectedly, a new drug-resistant ‘superbug’ pops up in the United States

For years, public health experts have warned us that deadly bacteria are developing resistance to all our available antibiotics. This week, researchers reported the first known U.S. case of an Escherichia coli infection resistant to colistin, a harsh drug seen as a last resort to knock out stubborn infections. The finding, described in the American Society for Microbiology journal Antimicrobial Agents and Chemotherapy, is no big surprise to researchers tracking the rise of resistant bacteria. The resistance gene, known as mcr-1, was discovered in E. coli in China last year, and has since cropped up in Europe.

As the United States crosses the same ominous milestone, research to understand resistance and develop new drugs is surging ahead. As Science reported earlier this month, evolutionary biologists have recently revisited old dogma about how best to prescribe antibiotics—revealing that trusted strategies such as using a high dose may not actually help prevent resistance.


E. coli bacteria growing in a dish.
Source: sciencemag

Monday, May 2, 2016

'Millions will die' from antimicrobial resistance unless we act now

From helping humans live longer and hacking our performance, to repairing the body and understanding the brain, WIRED Health will hear from the innovators transforming this critical sector.

Ten million people around the world will die each year by 2050 if more is not done to tackle the growing threat of antimicrobial resistance, Jim O'Neill, commercial secretary to the treasury, has said.

Speaking at WIRED Health, O'Neill said the rise in resistance needs to be "embraced by policy makers around the world".

If it isn't then the number of people dying from antimicrobial resistance (AMR) will increase dramatically.


Staphylococcus Aureus
Related Posts Plugin for WordPress, Blogger...

AddToAny